News Releases

Date	Title	Document
Date Feb 09, 2021	Title Oncocyte Announces Closing of $40 Million Public Offering of Common Stock	Document PDF
Date Feb 05, 2021	Title Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock	Document PDF
Date Feb 04, 2021	Title Oncocyte Announces Proposed Public Offering of Common Stock	Document PDF
Date Feb 02, 2021	Title Oncocyte Announces Definitive Agreement to Acquire Chronix Biomedical, Inc.	Document PDF
Date Jan 28, 2021	Title Oncocyte to Present New Data at the IASLC 2020 World Conference on Lung Cancer	Document PDF
Date Jan 20, 2021	Title Oncocyte Announces $25 Million Registered Offering	Document PDF
Date Jan 12, 2021	Title Oncocyte to Present at the 23rd Annual Needham Virtual Growth Conference	Document PDF